Why are patent applications for HIV prevention drugs facing opposition in India
Examining the reasons behind the opposition faced by patent applications for HIV prevention drugs in India.
- Cost concerns: Some HIV prevention drugs are expensive, which may limit access for those in need.
- Public health implications: Critics argue that patents could restrict availability and affordability of essential medications for HIV prevention.
- Healthcare system strain: Limited patent protection may encourage generic competition, potentially easing the burden on India's healthcare system.
- Ethical considerations: Access to life-saving medications is considered a human right, and patent restrictions may undermine this principle.
Answered
7 months ago